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ETd increasad by 21% (p s 0.01), NYHA functional claas by 0.7 (I-IV; p <
0.01).
Conclusion: DDD-pacing with short AV-delay decreases the outflow tract
gradient, relieves symptoms and improves QoL in patients with hyperfrophic
obstructive cardiomyopathy. Therefore, pacing should be considered as an
alternative to myectomy in such patients.
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n7962 Long-Term Effects of DDD Pscing on Hypertrophy
and LV Syatolic Function in Hypertrophic
Obstructive Cardiomyopathy
D. Pavin, C. de Place, H. Ie Breton, C. Leclercq, D. Gras, P.Mabo,
J.C. Daubefl. Department of Cardio/ogx UrriveraifyHospita/, Rermes,
France
DDD pacing reduces left ventricular outflow tract (LVOT) gradient and im-
proves functional status in patients with hypettrophic obstructive cardiomy-
opathy (HOCM). Little is known about long-term LV changes induced by this
therapy. Thia study was undertaken to assess the long-term (23 months)
effect of DDD pacing on LVfunction, cavity size and wall thickness with serial
echo-Doppler analysis.
20 patients (pts) with HOCM (LVOT gradient 230 mmHg) were implanted
with DDD pacemakers (PM) and followed for up to 62 months (21 + 18
montha). At the end of follow-up (FU), all pts reported symptomatic improve-
ment. LVOT gradient decreased from 96 + 36 mmHg to 30 + 33 mmHg (p
< 0.0001). In 16 pts, LVOT gradient decrease was progressive over time.
There was a slight but significant decrease in some LV hypertrophy indexes.
LV hyperkinesia was significantly reduced: LV end-diastolic volume was un-
changed.
Before imdant End-FU
Anteriorseptum (mm) 1s.7 * 4.5 17.6 *4.4 p c 0.05
Posteriorseptum (mm) 1s.5 * 4.4 17.5 *4.9 ns
Anteriorfree wall (mm) 14.9 *4 13.5 * 3.9 p <0.05
Posteriorfree wall (mm) 11&2,9 11 + 1.9 ns
End diaatolicvolume (ml) 120 +38 117+ 29 na
End eystolicvolume (ml) 40* 17 47* 16 p <0.05
Ejectionfraction(“A) 67& 7 60+ 7 p <0,05
These data are consistent with a remodeling effect of chronic DDD pac-
ing, Changes in hyperfrophy and LV systolic function may account for a
progressive and sustained effect on LVOT gradient.
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n7963 Thallium 201 Myocardial Perfusion in Patients With
Hypertrophic Cardiomyopathy And DDD Pacing
A. Le Helloco, D. Gras, A. Devillers, D. Pavin, J.-C. Daubert, P.Bourguet,
C. Almange. Cardiology Depaflment, University Hospital, Rennes, France
DDDpacingcan be used in patients with severa hypertrophiccardiomyopathy
(HCM). Tha aim of this prospective study was to evaluate the influence of
DDD pacing on Thallium 201 perfusion abnormalities. 35 patients (pts) with
mean age 52.1 + 13.6 and HCM diagnosed by echocardiography were
divided in 2 groups: group 1 included 21 pts with DDD pacing and group
214 pts without DDD pacing. All pts underwent dipyridamole Thallium 201
tomography with redistribution before and after DDD pacing (mean dalay
= 18 months + 6) and coronary angiography. Septsdthickness (ST), left
ventricular end diastolic volumes (LVED) were studied in 2 groups. Thallium
images were divided in 16segments and the severity of reduction in Thallium
uptake was aeored using a four point grading system in each patient (1 =
normal uptake to 4: severe reduction).
Results:
Group 1 Group2
Age 4S.1 + 16.4 54.9 l 12.1 NS
S.T. (mm) 23* 3.5 16.7* 2,6 p <0.005
l%allium 201 defects lzpfe 2pts p <0.025
LVED (ml/mz) 63,9 & 4.4 60.1 + 12.S p <0.005
During follow-up, Thallium tOtal acoredecreases (19.4+5.6 before pacing
vs 16.2 * 4.9 pacing, p < 0.05). A good correlation was found between
Thallium 201 myocardial perfusion and improvement of dyspnea and angina
in group 1.
Corrc/uaion:Thallium 201 perfusion abnormalities could diminish in some
patients with severe MCH treated by DDD pacing.
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1796-4] Catheter Treatmentof HYPetirOPhiCObStruCtive
Cardiomyopathy: Acute and Mid-term Resulte
H. Seggewiss, U, Gleichmann, L. Faber, D. Fassbender, H.K. Schmidt,
S. Strick. Dept. of Cardiology Heart Center NRW, Bad Oeynhausen,
Germany
In HOCM negative inotropic drugs, DDD-pacing, and surgical myectomy
reduce left ventricular outflow tract (LVOT) gradient. Catheter treatment of
HOCM by chemical non-surgical myocardial ablation was described as a
new therapeutic option.
24 symptomatic pts. (12 women; maan age 55.4 years; 3 pts. with prior
surgical mysctomy; 2 pts. with DDD-pacing; 11pts. with prior syncope; NYHA
class 2.6 +0.6). were treated. 1.3 ~ 0.6 (l-3) septel branches were occluded
by injection of 4,2 + 2.6 ml 96% alcohol in order to ablate the saptal bulge,
thus reducing LVOTgradient. Priortopermanent occlusion reduction of LVOT
gradients were estimated after 5 min. balloon dilatation of the target veasel.
LVOT gradients were reduced from 60.1 + 32.7 (38-149) mmHg to 20.0
+ 21.7 (O-74) mmHg at rest (p c 0.0001) and from 141.4+ 45.1 (78-240)
mmHg to 45.1 + 31.1 (B-99) mmHg post ES (p < 0.0001). 12 (50%) pta.
had complete AV-Block 10 min. up to 5 daye, requiring temporary (n =8) or
permanent (DDD-; n =4) pacing. A 86 year old woman died from ventricular
fibrillation 8 days after the procedure. After 3 months 15 controlled pta.
had ongoing clinical improvement. Hemodynamic control showad ongoing
reduction of LVOT gradients at rest (21.9 + 19.4 mmHg) and post ES (43.3
+ 28.9 mmHg).
Conclusion: Catheter treatment of HOCM seems to be a promising tech-
nique for non-surgical myocardial reduction in HOCM, thus reducing LVOT
gradients, Mid-term follow-up showed ongoing clinical and hemodynamic
improvement. Long-term follow is necessary to estimate the definitive signif-
icance of this naw therapy.
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[7’96-5/Left ventri~ulardiasto,ic function in HOCMafter
successful non-surgical septal reduction
M.Y.Henein, A.S. Kurbaan, C. Knight, U. Sigwan, D.G. Gibson. Royal
Brompton Hospital, London, UK
Diastolic Ieffventricular funetion has proved important in predicting long-term
follow-up in different cardiac diseases. Non-surgical septal reduction haa
also proved successful in reducing the ventricular outflow tract gradient and
improves symptoms. In order to assess its possible effects on diastole, we
studied 12 patients, age 51 + 18 years 6 female, with M-mode and 2 D echo-
Doppler technique and compared them with 21 normal subjeeta of similar
age. Before-procedure.’LVdimensions reduced 4.2+0.9 vs 4.9 +0.5 cm (VS
normal) at end-diastole and 2.4 * 0.7 vs 3.3 + 0.5 cm at end-systole as was
peak thinning rate 8.2 + 2.6 vs 11 + 2.7 cm/s but fractional shortening was
increased 43 * 8% vs 30 + 10Yo,p <0.001 each. Interventricular septum
was thickened 2.6 + 0.8 vs 1.0 + 0.1 cm as was the posterior wall 1.5 + 0.5
vs 1.0+ 0.1 cm, p <0.001 each. Transmitrd A wave velocity was high 76+
29 vs 50 & 10 cmls and E/A ratio low 1.1 + 1.3 vs 1.4 + 0.4, p <0.01 each.
PO.stprocedure:LVoutflow tract gradient fell from 67 + 42 to 11 + 8 mmHg,
p <0.001, symptoms improved but ventricular filling flaw velocities and peak
thinning rate did not change.
Conclusion: Successful non-surgical septel ablation reduces LV outflow
tract gradient and improves symptoms. Although itablateapartof thaproximal
septum, it does not alter the overall diastolic ventricular function.
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1796.61DoesMYo~ardia,cate~ho,eminecon~nt~ation
Reflect Ventricular Function in Heart Muscle
Disease?
Petar M. Seferovic, Stepan Stepanovic, RuZica Maksimovic,
Miodrag Ostojic, Dragana Seferovic, Slavko Simeunovi6, Arsen Ristic.
Inatitute of Cardiovascular Diaeases, Medical Center of Serbia, Belgrade,
Yugoslavia
The relationship of myocardial ceteeholamines and the saverity of LV dys-
function in biopsy proven myocarditia (BPM), idiopathic dilated (DCM) and
hypertrophic cardiomyopathy (HCM) is still controversial. To investigate this
issue we correlated myocardial catecholamine concentrations (MCC) and LV
hemodynamic parameters, for each group of the pts. In addition, we ana-
lyzed diagnostic utility of MCC measurements in revealing the inherent group
differences between BPM, DCM, and HCM pts.
Our study included 86 pts, 20 of them with BPM (60% males, aged
18-42 yrs), 32 pts with DCM (75% males, aged 21-56 yrs), and 34 HCM
(84% males, aged 29-54 yrs). At the initial assessment all pts underwent
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cardiac catheterization, measurements of related hemodynamic parame-
ters and EMB. Myocardial norepinephrine (MNEC), epinephrine (MEC), and
dopamine (MDC) concentrations were assayed using cateohol-O-methyl-
tranaferase radioenzymatic method and the obtainad values were expressed
as nglg of fresh tissue. The following mrrelations with LV parameters were
found (“”ps 0.01):
6PM DCM HCM
MNEC MEC MDC MNEC MEC MDC MNEC MEC MDC
LVEF 0.34 0.08 –0.02 0.89** 0.S68’ 0.02 0.71;” 0.80”” 0.12
LVdp/J 0.33 –0,18 0.09 0.67”’ 0.74”” 0.07 0.s0$” 0.77’” 0.07
I.vEDP –0.09 –0.13 –0.23 –0.79”” –0.75”” –0.11 0.16 0.05 –0.31-----
PCWP -0.22 0:17 –0.14 –0.63”” –0.76** –0.07 0.02 –0.03 –0.17
Furthermore, the comparison of MCC among investigated groups re-
vealed the following differences:
BPM DCM HCM
MNEC 415.4 * 71.1” 262.2 & 6S.9* 781.0+ 125.1”
MEC 57.3 * 4.6* 36.9 + 7.1* 91.3* 13.1”
MDC 76.6 ~ 9.2 ns 72.6 + 12.1 ns 76.1 + 9.3 ns
lp <0,01 (BPM VS.DCM); ‘p s 0,01 (HCM VS,BPM);*p s 0.01 (HCM VS.DC).
In mnclusion, these date suggest that MNEC and MEC strongly correlate
with LV hemodynamic parameter in DCM and HCM, but MDC does not.
Moreover, highest MNEC and MEC were demonstrated in the HCM group,
while their values were significantly increased in BPM pts in comparison to
DCM group.
c1797 PTCA and Stents in Acute Myocardial
Infarction
Wednesday,March19,1997,2:00p.m.-3:3Op.m.
AnaheimConventionCenter,RoomAl
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m7971 Primary Angioplasty Vsraus Thrombolysis With tPAin Anterior Myocardial Infarction: Resulta From a
Single Csntsr Trial
E. Garcia, J. Elizega, J. Soriano, M. Abeytua, J. Betas, A. Fernandez,
R. Rubio, E. Lopez, J. Lopez-Sendon, J.L. Delcan. Ffospita/Gregorio
Marar%n, Madrid, Spain
Although the special benefit of primary angioplasty (PA)compared withtPA in
patients (P) with anterior myocardial infarction (AMI) observed in a previous
trial haa been challenged in a larger recent study, no randomized trials have
been conducted including only P with AMI. We have recently concluded a
study comparing PAwith tPA in Pwith AMI, who were admitted to the hospital
no later than 5 h from the onset of pain. A total of 189 P (95 treatad with
PA and 94 with tPA) were included. Both groups were balanced with similar
baseline characteriatica. All the P received aspirin (126-325 mg/day). P in
the PA group received a bolua of 10.000 IU of heperin followed by 1000 IU/h
for 46 h and Pin tPA group received only Im ILf/hfor 48 h. The time from
oneat of pain to treatment wee 214+7 minutes for PAand 198 + 7fortPA (p
= NS). Permeability of the infarct relatad arIety (left anterior descanding-1-AD)
was teatad in both groups by cardiac catheterization (CC) before discharge.
The major adverse events in both groups are the following:
Mortality Reinfarction CVA
PA 3.1% 4.2% 3.2”h
T 10.6”A 4.2% o
. mm NS NS
Recurrent iechemia was present in 14.8% of Ptreated with PAand 30.8%
of P with tPA (p = 0.009). Angioplasty of the LAD was performed in 9.57.
of P treated with PA and 34% with tPA (p c 0.00001). TIMI Ill at the CC
prediacharge was present in 66% of the PA P and 58% of the tPA (p =
0.0004), and reaidual stenosis of the IAD was 34% after PA and 69% after
tPA (p < 0.00001).
In cone/usion:A study conducted only in P with AMI in a single center has
proved a reduction in mortality, recurrent ischemia, residuai stenosis, and
need for ravascularizationof the LAD in P treatad with PA compared with
tPA.
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What is the Ciinicai Outcome and Impact of
Ravascularization of TIMI 2 Flow Followina Acuts
Myocardiai Infarction?
G.R. McKendall, E.M. Antman, E. Braunwald, M.J. McDonald,
D.O. Williams for the TIMI 96 Investigators. Rhode /s/and Hospita/,
Providence, R\, USA, Brigham and Women3 Hospital, Boston, MA, USA
Although TIMI flow grade 2 (FG2) represents suboptimal reperfusion follow-
ing thrombolysis (T) for acute myocardiai infarction (AMI), the associated
clinical events and value of routine revascularization (REV) in such patienta
(pts) are unknown, We evaluated the clinical outcome of 328 pts treated with
either t-PA or streptokinase in TIMI 9B who had FG2 in their infarct related
arte~ during initial hospitalization. All pts (ALL) were followed for 30 to 80
days. The post discharge outcoma of ptstreatad with medical tharapy (MED,
n = 110, 34%) was compared to pts treated with REV during initial hospital-
ization (n= 218, S&%).Of pts traated with REV,19% had CABG and 81% had
PTCA (successful in 87% and partially successful in 7%), Baseline clinical
and hemodynamic characteristics were similar in both groups. in hospital
mortality was 8 (3.7%) and 1 (0.9%) for REV and MED (p= 0.137).
ClinicalOutcomeFromDischargeThrough60 Days
ALL n (%) REV n (%) MED n (%) p
Death 4 (1.3) 1 (0.5”/0) 3 (2.s”/.) 0.118
ReMl 1S (6”/0) s (4”/.) 10 (9°/6) 0,050
CHF 2 (0.60/.) 2 (l%) o (0”/0) o.43t
Angina 69(22”/0) 37(1s%) 32 (29%) 0.017
Readmissionforcardiscevent 61(t9%) 30(14”/0) 31 [2s%) 0.003
REV during hospitalization in pts with FG2 following T reduced subse-
quent ischemic avents after hospital diacharge.
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797-3 A Prospsctiva Multicsnter Triai Uaing the JJiS
Hsparin-Coated Stsnt for Primary Reperfueion of
Acuta Myocardial infarction
C.L. Grines, M.-C. Morice, L. Mattes, G.W. Stone, W. O’Neill, B. Firth,
E.G. Fernandez, F. Kiemeney, D. Jones, P.W.Serruys. William Baaumont
Hospital, Royal Oak, MI, USA, Thoraxcentec Rotterdam, Netherlands
Prtmaty stenting for acute myocerdial infarction is being performed with in-
creasing enthusiasm, however, due to concerns about stent thrombosis,
potent antiplatelet, anticoagulants and thrombdytic drugs have been admin-
istered to many patients, with resultant increase in hospital stay and cost.
The heperin-coated stent decreases platelet deposition by 95% compared
to an uncoated stent. We hypothesized that the heparin-coatad stent could
safely establish reperfusion, eliminate the need for post procedural anticoag-
ulation, and potentially reduce bleeding complications, ischemic events and
restenosis compared to other reperfusion strategies. In this 100 patient pilot
study, acute Ml patients are taken dire@lyto the catheterization laboreto~,
where prediiatation of the infarct-related vessel is performed. If the iumen
size is 23.0 mm, one or more heparin-coated stents are placad. If an optimal
stent result is achiaved (residual stenosis <10%, good flow, and absence
of residual filling defect or unstentad diasaction), no additional heparin ia
given. Thrombolytics, ReoPro and warfarin are avoidad. Clinical events are
monitored to 8 months, at which time follow-up angiography ia performed for
determination of reocclusion and restenosis rates. To date, 60 of the antici-
pated 100 patients hava been enrolled, and complete date will be available
by March of 1997. This pilot study will ba followed by a multicenter, inter-
national trial comparing the heparin-coated stent to prima~ PTCA for acute
myocerdial infarction.
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ml ~afstyandF~aSibilityOfPrimaf’y~enthIgin A.ute
Myocardiai infarction - In-hospital and 30 Day
Rssuits of tha PAMI Stent Pilot Trial
G.W. Stone, B. Brodie, J. Griffin, F.St. Gear, M.-C. Morice, C. Costantini,
p,A. overlie, D. Jones, W.W. O’Neill, C.L. Grines. The CafdiOVaSCU/af.
hrstitute, .E/Camino Hospital, Mountain View, CA, USA
Primay stenting in AMI has the potential to improva Iateoutcomes compared
to primary PTCA. A multicenter, prospective trial was therefore parformad
in which 300 pts with AMI underwent primary PTCA, followed by stenting
in all pts in the absence of contraindications. Pta were excluded only for
cerdiogenic shock and symptoms >12 hours. Major exclusions for stenting
were vessel size <2.75 mm, length 23 stents, giant thrombus, and the
expected inability to deliver or expand tha stent. Mean aga was 61 + 12
